Publications by authors named "Ruijuan Xing"

Claim this Profile
T
Tunable Site Selectivity and Chemo- and Regioselectivity: Diversification of Indole Alkaloid Privileged Scaffolds Enabled by λ-Iodane-Mediated Cross-Nucleophile Coupling Cascade.
Zenghui Sun, Ziyi Zhang, Ran Guo, Yan Fu, Lu Yang, Ruijuan Xing

Org Lett· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and Synthesis of FR-β Targeting Chimeric Molecules for Reprogramming Tumor-Associated Macrophages Using 6-Substituted Pyrrolo[2,3-]pyrimidines as Targeting Ligands.
Lixiao Guo, Binghao Guo, Yuqing Wang, Yuwei Zheng, Shuo Sun, Ruijuan Xing

J Med Chem· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KCO-Catalyzed (3 + 2) Cycloaddition Reaction of -2,2,2-Trifluoroethylisatin Ketimines with Azodicarboxylates: Access to Spirooxindoles Containing Trifluoromethyl-1,2,4-triazolines.
Jianmin Gu, Xiaojing Li, Yabo Zhang, Zenghui Sun, Lin Li, Ruijuan Xing

J Org Chem· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of novel tumor-targeted near-infrared probes with 6-substituted pyrrolo[2,3-d]pyrimidines as targeting ligands.
Yining Zhang, Zijun Luo, Lixiao Guo, Haofeng Zhang, Tongdan Su, Ruijuan Xing

Eur J Med Chem· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis and biological evaluation of pyrrolopyrimidine derivatives as novel and selective positive modulator of the small conductance Ca-activated K channels.
Ran Guo, Miao Cui, Xiaojing Li, Mengqi Wu, Fei Xu, Ruijuan Xing

Eur J Med Chem· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, bioavailability, and plasma protein binding study of glytrexate, a novel multitarget antifolate.
Jiahong Xiang, Mengqi Wu, Jianchao Wang, Mengmeng Lin, Mengmeng Sun, Ruijuan Xing

Front Pharmacol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a Highly Selective β-Adrenoceptor Agonist with a 2-Amino-2-phenylethanol Scaffold as an Oral Antiasthmatic Agent.
Gang Xing, Dahong Li, Anthony Yiu-Ho Woo, Zhengxing Zhi, Lei Ji, Ruijuan Xing

J Med Chem· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis and antitumor activity of aromatic urea-quinazolines.
Zhao Yang, Jian-Min Gu, Qiu-Ya Ma, Na Xue, Xiao-Wei Shi, Rui-Juan Xing

Future Med Chem· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of β-arrestin-biased β-adrenoceptor agonists from 2-amino-2-phenylethanol derivatives.
Anthony Yiu-Ho Woo, Xin-Yue Ge, Li Pan, Gang Xing, Yong-Mei Mo, Rui-Juan Xing

Acta Pharmacol Sin· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, biological evaluation and molecular modeling of 2-amino-2-phenylethanol derivatives as novel β-adrenoceptor agonists.
Xinyue Ge, Yongmei Mo, Gang Xing, Lei Ji, Haiyan Zhao, Ruijuan Xing

Bioorg Chem· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel 6-substituted benzoyl and non-benzoyl straight chain pyrrolo[2,3-d]pyrimidines as potential antitumor agents with multitargeted inhibition of TS, GARFTase and AICARFTase.
Ruijuan Xing, Hongying Zhang, Jiangsong Yuan, Kai Zhang, Lin Li

Eur J Med Chem· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Selective Pharmacophore Model for beta(2)-Adrenoceptor Agonists.
Rui-Juan Xing, Jian Wang, Li Pan, Mao-Sheng Cheng

Molecules· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis